{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "EU Pharma Legislation Review Series: Bolar Exemption under Patent Rights",
    "url": "https://www.lexblog.com/2023/05/02/eu-pharma-legislation-review-series-bolar-exemption-under-patent-rights/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-Z2EM53C6",
        "url": "https://www.lexblog.com/lib/Z2EM53C6/"
    },
    "datePublished": "2023-05-02T05:00:00-04:00",
    "dateModified": "2023-05-02T09:29:07-04:00",
    "author": {
        "@type": "Person",
        "name": "Robin Blaney"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Covington & Burling LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Inside EU Life Sciences",
    "about": "Intellectual Property",
    "sourceUrl": "https://www.insideeulifesciences.com/?p=7707",
    "sourceStability": "may-move"
}